/ /

  • linkedin
  • Increase Font
  • Sharebar

    PiXL appears promising for low myopia

    Epi-on method reduced myopia by about 0.25 D; effect averaged 1.25 D in high oxygen

    Take-home: The use of epi-on photorefractive intrastromal cross linking reduced myopia by about 0.25 D in a small study; In a high-oxygen group, the effect averaged 1.25 D.

    Photorefractive intrastromal crosslinking—or PiXL for short—may be a potential new treatment for low-grade myopia, according to Anders Behndig, MD, Department of Clinical Sciences/Ophthalmology, Umea University Hospital, Umeå, Sweden.

    Dr. Behndig presented information about his ongoing study, which included healthy volunteers with myopia in the range of -0.5 and -2.6 D (mean, -1.5 D).

    All volunteers had epithelium-on (epi-on) PiXL treatment. This treatment included the use of topical anesthesia, isotonic riboflavin that was applied every 90 seconds for 10 minutes, and pulsed crosslinking. A circular central 4-mm cornea zone was irradiated with 30 mW/cm2 for 16:40 minutes.

    Two groups

    New Call-to-action


    You must be signed in to leave a comment. Registering is fast and free!

    All comments must follow the ModernMedicine Network community rules and terms of use, and will be moderated. ModernMedicine reserves the right to use the comments we receive, in whole or in part,in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.

    • No comments available


    View Results